首页> 美国卫生研究院文献>The Journal of Chemical Physics >Parameterization of a drug molecule with a halogen σ-hole particle using ffTK: Implementation testing and comparison
【2h】

Parameterization of a drug molecule with a halogen σ-hole particle using ffTK: Implementation testing and comparison

机译:使用 ffTK 对具有卤素 σ 孔颗粒的药物分子进行参数化:实施、测试和比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Halogen atoms are widely used in drug molecules to improve their binding affinity for the receptor proteins. Many of the examples involve “halogen bonding” between the molecule and the binding site, which is a directional interaction between a halogen atom and a nucleophilic atom. Such an interaction is induced by an electron cloud shift of the halogen atom toward its covalently bonded neighbor to form the σ-bond, leaving a small electrostatic positive region opposite to the bond called the “σ-hole.” To mimic the effect of the σ-hole in the CHARMM non-polarizable force field, recently CGenFF added a positively charged massless particle to halogen atoms, positioned at the opposite side of the carbon–halogen bond. This particle is referred to as a lone pair (LP) particle because it uses the lone pair implementation in the CHARMM force field. Here, we have added support for LP particles to ffTK, an automated force field parameterization toolkit widely distributed as a plugin to the molecular visualization software VMD. We demonstrate the updated optimization process using an example halogenated drug molecule, AT130, which is a capsid assembly modulator targeting the hepatitis B virus. Our results indicate that parameterization with the LP particle significantly improves the accuracy of the electrostatic response of the molecule, especially around the halogen atom. Although the inclusion of the LP particle does not produce a prominent effect on the interactions between the molecule and its target protein, the protein–ligand binding performance is greatly improved by optimization of the parameters.
机译:卤素原子广泛用于药物分子中,以提高它们与受体蛋白的结合亲和力。许多例子涉及分子和结合位点之间的“卤素键”,这是卤素原子和亲核原子之间的定向相互作用。这种相互作用是由卤素原子的电子云移向其共价键合的邻居以形成σ键引起的,从而在键对面留下一个称为“σ空穴”的小静电正区域。为了模拟 CHARMM 非极化力场中σ孔的效果,最近 CGenFF 在卤素原子上添加了一个带正电荷的无质量粒子,该粒子位于碳-卤素键的另一侧。该粒子被称为孤对 (LP) 粒子,因为它在 CHARMM 力场中使用孤对实现。在这里,我们在 ffTK 中添加了对 LP 粒子的支持,ffTK 是一个自动力场参数化工具包,作为分子可视化软件 VMD 的插件广泛分发。我们使用一个示例卤代药物分子 AT130 来演示更新的优化过程,AT130 是一种靶向乙型肝炎病毒的衣壳组装调节剂。我们的结果表明,使用 LP 粒子进行参数化可显著提高分子静电响应的准确性,尤其是在卤素原子周围。尽管 LP 颗粒的加入不会对分子与其靶蛋白之间的相互作用产生显著影响,但通过优化参数,蛋白质-配体结合性能得到了大大提高。

著录项

代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号